Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1724-1732

  Olsen, Anja Weinreich ^a,b   Hansen, Paul Robert ^a,b   Holm, Arne ^a,b   Andersen, Peter ^a,b  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antigen presentation; Epitope; Peptide; Vaccination

Indexed keywords

BCG VACCINE; EPITOPE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EMULSION; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; TUBERCULOSIS; VACCINATION;

EID: 0034040571     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A     Document Type: Article

References (44)

1. Anonymous, Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the eliminating of tuberculosis (ACET). MMWR. Mort). Mortal. Wkly. Rep. 1998.47: 1-6.
2. Fine, P. E., Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995. 346:1339-1345.
3. Ben-Yedidia, T., Marcus, H., Reisner, Y. and Arnon, R., Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. Int. Immunol. 1999. 11: 1043-1051.
4. Volpina, O. M., Surovoy, A. Y., Zhmak, M. N., Kuprianova, M. A., Koroev, D. O., Chepurkin, A. V., Toloknov, A. S. and Ivanov, V. T., A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Vaccine 1999.17:577-584.
5. Langeveld, J. P., Casal, J. I., Osterhaus, A. D., Cortes, E., deSwart, R., Vela, C., Dalsgard, K., Puijk, W. G., Schaaper, W. M. and Meloen, R. H., First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol. 1994. 68: 4506-4513.
6. Langeveld, J. P., Kamstrup, S., Uttenthal, A., Strandbygaard, B., Vela, C., Dalsgaard, K., Beekman, N. J., Meloen, R. H. and Casal, J. I., Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein. Vaccine 1995. 13: 1033-1037.
7. Sercarz, E. E., Lehmann, P. V. and Ametani, A., Benichou, G., Miller, A. and Moudgil, K., Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 1993.11:729-766.
8. Gegin, C. and Lehmann-Grube, F., Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J. Immunol. 1992.149: 3331-3338.
9. Cole, G. A., Hogg, T. L., Coppola, M. A. and Woodland, D. L., Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. J. Immunol. 1997. 158:4301-4309.
10. Brandt, L., Oettinger, T., Holm, A. and Anderson, P., Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J. Immunol 1996.157:3527-3533.
11. Ulrichs, T., Munk, M. E., Mollenkopf, H., Behr-Perst, S., Colangeli, R., Gennaro, M. L. and Kaufmann, S. H., Differential T cell responses to Mycobacterium tuberculosis ESAT-6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 1998. 28: 3949-3958.
12. Ravn, P., Demissie, A., Eguale, T., Wondwosson, H., Lein, D., Amoudy, H., Mustafa, A. S., Jensen, A. K., Holm, A., Rosenkrands, I., Oftung, F., Olobo, J., von-Reyn, C. F. and Andersen, P., Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 1999.179:637-645.
13. Pollock, J. M. and Andersen, P., Predominant recognition of the ESAT-6 protein in the first phase of infection with Mycobacterium bovis in cattle. Infect. Immun. 1997. 65: 2587-2592.
14. Brandt, L, Elhay, M. J., Rosenkrands, I., Lindblad, E. B. and Anderson, P., ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 2000. 68: 791-795.
15. Käst, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D. and Melief, C. J., Protection against lethal Sendai virus infection by in vivo priming of virusspecific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sei. USA 1991. 88: 2283-2287.
16. Cole, G. A., Hogg, T. L. and Woodland, D. L, The MHC class Irestricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 1994. 6:1767-1775.
17. van-der-Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M. and Ahmed, R., Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 1996. 157: 5543-5554.
18. Boesen, H., Jensen, B. N., Wilcke, T. and Andersen, P., Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 1995. 63:1491-1497.
19. Havlir, D. V., Wallis, R. S., Boom, W. H., Daniel, T. M., Chervenak, K. and Ellner, J. J., Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 1991. 59: 665-670.
20. Haslov, K., Andersen, A., Nagai, S., Gottschau, A., Sorensen, T. and Andersen, P., Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect. Immun. 1995.63:804-810.
21. Andersen, P., Askgaard, D., Gottschau, A., Bennedsen, J., Nagai, S. and Heron, I., Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand. J. Immunol. 1992. 36: 823-831.
22. Pathan, A., Brookes, R., Pritchard, H., Wilkinson, R., Pasvol, G., Hill, A. and Lalvani, A., Human T cell responses to the antigen ESAT-6 characterize a vaccine candidate and potential diagnostic test for tuberculosis. Immunology 1998. 95 (Suppl 1): 90.
23. Vijh, S., Pilip, I. M. and Pamer, E. G., Effect of antigenprocessing efficiency on in vivo T cell response magnitudes. J. Immunol. 1998.160: 3971-3977.
24. Adorini, L., Appella, E., Doria, G. and Nagy, Z. A., Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 1988. 168: 2091-2104.
25. Brett, S. J., Cease, K. B. and Berzofsky, J. A., Influence of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing. J. Exp. Med. 1988.168: 357-373.
26. Deng, H., Fosdick, L. and Sercarz, E., The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance. APMIS 1993.101: 655-662.
27. Deng, Y., Yewdell, J. W., Eisenlohr, L. C. and Bennink, J. R., MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class l-restricted peptides recognized by antiviral CTL. J. Immunol. 1997. 158: 1507-1515.
28. Germain, R. N., MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994. 76:287-299.
29. Harboe, M., Wiker, H. G., Ulvund, G., Malin, A. S., Dockrell, H., Holm, A., Joergensen, M. C. and Andersen, P., B cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect. Immun. 1998. 66: 717-723.
30. Hubbard, S. J., Campbell, S. F. and Thornton, J. M., Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J. Mol. Biol. 1991. 220: 507-530.
31. Novotny, J. and Bruccoleri, R. E., Correlation among sites of limited proteolysis, enzyme accessibility and segmental mobility. FEBS Lett. 1987. 211:185-189.
32. Andersen, P., Andersen, A. B., Sorensen, A. L. and Nagai, S., Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 1995.154: 3359-3372.
33. Andersen, P., Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 1994. 62: 2536-2544.
34. Oukka, M., Manuguerra, J. C., Livaditis, N., Tourdot, S., Riche, N., Vergnon, I., Cordopatis, P. and Kosmatopoulos, K., Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J. Immunol. 1996.157: 3039-3045.
35. Inaba, K. and Steinman, R. M., Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J. Exp. Med. 1984. 160: 1717-1735.
36. Luqman, M. and Bottomly, K., Activation requirements for CD4T cells differing in CD45R expression. J. Immunol. 1992. 149: 2300-2306.
37. Bachmann, M. F., Gallimore, A., Linked, S., Cerundolo, V., Lanzavecchia, A., Kopf, M. and Viola, A., Developmental regulation of Lck targeting to the CDS receptor controls signaling in naive and memory T cells. J. Exp. Med. 1999.189:1521 -1530.
38. Busch, D. H. and Pamer, E. G., T cell affinity maturation by selective expansion during infection. J. Exp. Med. 1999. 189: 701-710.
39. Mustafa, A. S., Amoudy, H. A., Wiker, H. G., Abal, A. T., Ravn, P., Oftung, F. and Andersen, P., Comparison of antigen specific T cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand. J. Immunol. 1998.48:535-543.
40. Mehra, V, Gong, J. H., lyer, D., Lin, Y., Boylen, C. T., Bloom, B. R. and Barnes, P. F., Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J. Infect. Dis. 1996. 174: 431-434.
41. Andersen, P., Askgaard, D., Ljungquist, L., Bennedsen, J. and Heron, I., Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 1991. 59:1905-1910.
42. Chang, C. D. and Meienhofer, J., Solid-phase peptides synthesis using a mild base cleavage of dihydrosomatostatin. Int. J. Pept. Protein Res. 1978.11: 246-249.
43. Tarn, J. P., Synthetic peptides vaccine design: synthesis and properties of high density multiple antigenic peptide system. Proc. WatJ. Acad. Sei. USA 1988. 85: 5409-5413.
44. Andersen, P., Askgaard, D., Ljungquist, L., Bentzon, M. W. and Heron, I., T cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 1991. 59: 1558-1563.